Katherine M Krajewski
Overview
Explore the profile of Katherine M Krajewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1803
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Najem E, Shaikh M, Shinagare A, Krajewski K
Cancer Imaging
. 2025 Feb;
25(1):16.
PMID: 39966980
Background: Research has helped to better understand renal cell carcinoma and enhance management of patients with locally advanced and metastatic disease. More recently, artificial intelligence has emerged as a powerful...
2.
Jammihal T, Saliby R, Labaki C, Soulati H, Gallegos J, Peris A, et al.
Nat Cancer
. 2025 Jan;
6(2):372-384.
PMID: 39789182
Immune checkpoint inhibitors can lead to 'exceptional', durable responses in a subset of persons. However, the molecular basis of exceptional response (ER) to immunotherapy in metastatic clear cell renal cell...
3.
Schawkat K, Krajewski K
Hematol Oncol Clin North Am
. 2023 Jun;
37(5):863-875.
PMID: 37302934
This article presents a comprehensive overview of new imaging approaches and techniques for improving the assessment of renal masses and renal cell carcinoma. The Bosniak classification, version 2019, as well...
4.
Lee L, Krajewski K, Suarez-Weiss K, Silverman S, Shinagare A
Curr Probl Diagn Radiol
. 2022 Jul;
51(6):818-822.
PMID: 35842346
Rationale: Substantial organizational changes, increasing clinical volumes, and the COVID-19 pandemic presented compound stressors to faculty radiologists in our large academic abdominal radiology division and necessitated multiple changes in our...
5.
Park H, Qin L, Bakouny Z, Krajewski K, Van Allen E, Choueiri T, et al.
Oncologist
. 2022 Mar;
27(5):389-397.
PMID: 35348767
Background: The treatment responses of immune checkpoint inhibitors in metastatic renal cell carcinoma (mRCC) vary, requiring reliable prognostic biomarkers. We assessed the prognostic ability of computed tomography (CT) texture analysis...
6.
Hirsch L, Martinez Chanza N, Farah S, Xie W, Flippot R, Braun D, et al.
JAMA Oncol
. 2021 Oct;
7(12):1815-1823.
PMID: 34673916
Importance: Patients with brain metastases from renal cell carcinoma (RCC) have been underrepresented in clinical trials, and effective systemic therapy is lacking. Cabozantinib shows robust clinical activity in metastatic RCC,...
7.
Rana H, Koeller D, Schwartz A, Manning D, Schneider K, Krajewski K, et al.
Eur J Med Genet
. 2021 Oct;
64(12):104359.
PMID: 34628056
Von Hippel-Lindau (VHL) syndrome is a hereditary tumor syndrome associated with germline loss-of-function pathogenic variants (PVs) in the VHL gene. VHL is classically associated with a high penetrance for many...
8.
Pathoulas J, Flanagan K, Walker C, Ly A, Krajewski K, Wiss I, et al.
Dermatol Online J
. 2021 Jun;
27(5).
PMID: 34118814
Pulmonary carcinoid tumors are uncommon neuroendocrine tumors that rarely metastasize to the skin. We report the case of a 71-year-old woman with a longstanding history of primary atypical pulmonary carcinoid...
9.
Nassar A, Hamieh L, Gray K, Thorner A, Fay A, Lasseter K, et al.
Mol Cancer Ther
. 2019 Oct;
19(2):690-696.
PMID: 31653662
We previously showed that alterations in mTOR pathway genes were correlated with response to rapalog therapy in metastatic renal cell carcinoma (mRCC), when the analysis focused on extremes of response....
10.
Alessandrino F, DiPiro P, Jagannathan J, Babina G, Krajewski K, Ramaiya N, et al.
Insights Imaging
. 2019 Feb;
10(1):25.
PMID: 30796644
Indolent B cell lymphomas are a group of lymphoid malignancies characterized by their potential to undergo histologic transformation to aggressive lymphomas. While different subtypes of indolent B cell lymphomas demonstrate...